M S Bhatia1, Priyanka Gautam2, Anurag Jhanjee3. 1. Professor and Head, Department of Psychiatry, University College of Medical Sciences & Guru Teg Bahadur Hospital , Delhi, India . 2. Senior Resident, Department of Psychiatry, University College of Medical Sciences & Guru Teg Bahadur Hospital , Delhi, India . 3. Assistant Professor, Department of Psychiatry, Hamdard Institue of Medical Sciences & Research , Hamdard Nagar, Delhi, India .
Abstract
BACKGROUND: Chikungunya fever is an acute illness caused by an arbovirus and has various complications like neurological, psychological, dermatological and even multi organ failure. Psychiatric co-morbidity is not very well studied till now. This is the first report from India. AIM: Aim of the study was to assess the psychiatric morbidity during or after the onset of Chikungunya fever. MATERIALS AND METHODS: Patients referred from Medicine department with confirmed diagnosis of Chikungunya fever were recruited, after taking informed consent. Patient's socio-demographic characteristics were noted and Psychiatric co-morbidity was assessed by complete history taking and mental status examination, using WHO International Classification of Diseases, 10(th) edition (ICD -10) of Mental and Behavioural Disorders, Diagnostic criteria for research. RESULTS: The age range of the study group was found to be 23-48 years. Fourteen (70%) were males and 6 (30%) were females. Five (25%) patients were diagnosed with depressive disorder, 3 (15%) patients had Generalized Anxiety Disorder (GAD), 2 (10%) patients GAD with Panic attacks, 1(5%) patients phobic disorder (claustrophobia), 3 (15%) patients Somatoform Disorder, 3 (15%), Neurasthenia (Fatigue Syndrome), etc. Two (10%) patients presented with vague somatic complaints which did not fit into any of the diagnostic category. CONCLUSION: Chikungunya fever can result in significant psychiatric morbidity, mainly in the form of depressive episode, anxiety disorder and even long persisting illnesses like somato-form disorders. Further research is required to know about the phenomenology or the neurobiology of the psychiatric disorders occurring in the course of this illness.
BACKGROUND:Chikungunya fever is an acute illness caused by an arbovirus and has various complications like neurological, psychological, dermatological and even multi organ failure. Psychiatric co-morbidity is not very well studied till now. This is the first report from India. AIM: Aim of the study was to assess the psychiatric morbidity during or after the onset of Chikungunya fever. MATERIALS AND METHODS:Patients referred from Medicine department with confirmed diagnosis of Chikungunya fever were recruited, after taking informed consent. Patient's socio-demographic characteristics were noted and Psychiatric co-morbidity was assessed by complete history taking and mental status examination, using WHO International Classification of Diseases, 10(th) edition (ICD -10) of Mental and Behavioural Disorders, Diagnostic criteria for research. RESULTS: The age range of the study group was found to be 23-48 years. Fourteen (70%) were males and 6 (30%) were females. Five (25%) patients were diagnosed with depressive disorder, 3 (15%) patients had Generalized Anxiety Disorder (GAD), 2 (10%) patients GAD with Panic attacks, 1(5%) patientsphobic disorder (claustrophobia), 3 (15%) patients Somatoform Disorder, 3 (15%), Neurasthenia (Fatigue Syndrome), etc. Two (10%) patients presented with vague somatic complaints which did not fit into any of the diagnostic category. CONCLUSION:Chikungunya fever can result in significant psychiatric morbidity, mainly in the form of depressive episode, anxiety disorder and even long persisting illnesses like somato-form disorders. Further research is required to know about the phenomenology or the neurobiology of the psychiatric disorders occurring in the course of this illness.
Authors: Francesca Cavrini; Paolo Gaibani; Anna Maria Pierro; Giada Rossini; Maria Paola Landini; Vittorio Sambri Journal: J Infect Dev Ctries Date: 2009-12-15 Impact factor: 0.968
Authors: Sarah A Ziegler; Liang Lu; Amelia P A Travassos da Rosa; Shu-Yuan Xiao; Robert B Tesh Journal: Am J Trop Med Hyg Date: 2008-07 Impact factor: 2.345
Authors: Man-Koumba Soumahoro; Patrick Gérardin; Pierre-Yves Boëlle; Joelle Perrau; Adrian Fianu; Jacques Pouchot; Denis Malvy; Antoine Flahault; François Favier; Thomas Hanslik Journal: PLoS One Date: 2009-11-11 Impact factor: 3.240
Authors: Simona Ozden; Michel Huerre; Jean-Pierre Riviere; Lark L Coffey; Philippe V Afonso; Vincent Mouly; Jean de Monredon; Jean-Christophe Roger; Mohamed El Amrani; Jean-Luc Yvin; Marie-Christine Jaffar; Marie-Pascale Frenkiel; Marion Sourisseau; Olivier Schwartz; Gillian Butler-Browne; Philippe Desprès; Antoine Gessain; Pierre-Emmanuel Ceccaldi Journal: PLoS One Date: 2007-06-13 Impact factor: 3.240
Authors: Marion Sourisseau; Clémentine Schilte; Nicoletta Casartelli; Céline Trouillet; Florence Guivel-Benhassine; Dominika Rudnicka; Nathalie Sol-Foulon; Karin Le Roux; Marie-Christine Prevost; Hafida Fsihi; Marie-Pascale Frenkiel; Fabien Blanchet; Philippe V Afonso; Pierre-Emmanuel Ceccaldi; Simona Ozden; Antoine Gessain; Isabelle Schuffenecker; Bruno Verhasselt; Alessia Zamborlini; Ali Saïb; Felix A Rey; Fernando Arenzana-Seisdedos; Philippe Desprès; Alain Michault; Matthew L Albert; Olivier Schwartz Journal: PLoS Pathog Date: 2007-06 Impact factor: 6.823
Authors: Alfonso J Rodriguez-Morales; Karol Liceth Hoyos-Guapacha; Sara Lucia Vargas-Zapata; Oscar Mauricio Meneses-Quintero; Julio César Gutiérrez-Segura Journal: Rheumatol Int Date: 2017-05-26 Impact factor: 2.631
Authors: Claire J Heath; Jason Lowther; Trevor P Noël; Idis Mark-George; Derek B Boothroyd; George Mitchell; Calum MacPherson; A Desiree LaBeaud Journal: Open Forum Infect Dis Date: 2018-01-03 Impact factor: 3.835
Authors: Luisa I Alvarado; Olga D Lorenzi; Brenda C Torres-Velásquez; Tyler M Sharp; Luzeida Vargas; Jorge L Muñoz-Jordán; Elizabeth A Hunsperger; Janice Pérez-Padilla; Aidsa Rivera; Gladys E González-Zeno; Renee L Galloway; Mindy Glass Elrod; Demetrius L Mathis; M Steven Oberste; W Allan Nix; Elizabeth Henderson; Jennifer McQuiston; Joseph Singleton; Cecilia Kato; Carlos García-Gubern; William Santiago-Rivera; Robert Muns-Sosa; Juan D Ortiz-Rivera; Gerson Jiménez; Vanessa Rivera-Amill; Doris A Andújar-Pérez; Kalanthe Horiuchi; Kay M Tomashek Journal: PLoS Negl Trop Dis Date: 2019-07-22
Authors: Leora R Feldstein; Esther M Ellis; Ali Rowhani-Rahbar; Morgan J Hennessey; J Erin Staples; M Elizabeth Halloran; Marcia R Weaver Journal: PLoS Negl Trop Dis Date: 2019-07-19
Authors: Efrén Murillo-Zamora; Oliver Mendoza-Cano; Benjamín Trujillo-Hernández; Xóchitl Trujillo; Miguel Huerta; José Guzmán-Esquivel; Martha Alicia Higareda-Almaraz; Agustin Lugo-Radillo; Ignacio Moreno-Gutiérrez; Enrique Higareda-Almaraz; Mónica Ríos-Silva Journal: Int J Environ Res Public Health Date: 2018-11-14 Impact factor: 3.390